On July 15, 2024, Thomas Tu, Chief Medical Officer of Inari Medical Inc (NASDAQ:NARI), sold 16,520 shares of the company, according to the SEC Filing. Following this transaction, the insider now owns 313,257 shares of Inari Medical Inc. Warning! GuruFocus has detected 4 Warning Signs with NARI. Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. The company's innovative devices are designed to remove blood clots and restore healthy blood flow in the venous system. Over the past year, the insider has sold a total of 66,897 shares and has not made any purchases. This recent transaction is part of a broader trend observed over the past year, where Inari Medical Inc has seen 32 insider sells and only 2 insider buys. Shares of Inari Medical Inc were trading at $55.09 on the day of the transaction. The company has a market cap of approximately $3.37 billion. The stock's valuation metrics, including the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, are calculated based on historical trading multiples, adjustments for past performance, and future business expectations. According to the GF Value, the intrinsic value of Inari Medical Inc is estimated at $99.63 per share, suggesting that the stock is currently undervalued with a price-to-GF-Value ratio of 0.55. This valuation indicates a "Possible Value Trap, Think Twice" status. Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI) Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI) This insider sale could be of interest to investors monitoring insider behaviors and company valuation metrics to gauge potential investment opportunities or risks associated with Inari Medical Inc (NASDAQ:NARI). This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus.
Insider Sale: Chief Medical Officer Thomas Tu Sells Shares of Inari Medical Inc (NARI)
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...